JXR MEDI BARRI JOURNEY
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
- Investigator
- Michael D Schweitzer Barrios
- Status
- Accepting Candidates
- Ages
- 40 Years - 80 Years
- Sexes
- All
JXR MEDI MORA SPARKLE
A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy, in adolescent and adult Sickle Cell Disease…
- Status
- Accepting Candidates
- Ages
- 12 Years - 100 Years
- Sexes
- All
JXR MEDI MIRS AIRTIVITY
This study is open to adults and adolescents aged 12 to under 18 with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exacerbations).
The purpose of this study is to find out whether a…
- Investigator
- Michael D Schweitzer Barrios
- Status
- Accepting Candidates
- Ages
- 12 Years - N/A
- Sexes
- All